ArticleBriefings in bioinformatics2026
Optimal transport for label transfer in single-cell multi-omics integration.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Single-cell multi-omics datasets are rapidly expanding, and integrating complementary modalities can provide a more comprehensive view of the molecular mechanisms underlying biological processes. However, cross-modality alignment remains challenging due to modality-specific measurement differences and mismatches in cell-type proportions. Here, we present single-cell Optimal Transport-based Label Transfer (scOT-LT), a semi-supervised label-transfer framework that aligns single-cell RNA sequencing (scRNA-seq) and scATAC-seq data using label-aware unbalanced optimal transport, which tolerates compositional mismatch while favoring label-consistent correspondences. scOT-LT learns a shared embedding through unbalanced optimal transport-guided alignment and transfers cell-type labels from the annotated scRNA-seq reference to unlabeled scATAC-seq via entropic OT coupling. Evaluations on multiple real-world datasets show that scOT-LT achieves strong modality mixing and high label-transfer accuracy, remains robust under downsampled scRNA-seq annotations, and can reliably detect novel cell types. Thus, scOT-LT not only improves integration and label-transfer performance but also yields explicit, interpretable cross-modality coupling, providing a practical approach for multimodal integration and annotation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.